COP21 led to an agreed target of keeping the increase in global average temperature well below 2°C compared to pre-industrial levels. Due to its high potential for decarbonisation, the building stock will have to contribute a reduction of at least 85-95% in greenhouse gas (GHG) emissions until 2050. Policy-driven scenario analysis is, therefore, important for assisting policy makers who are called upon to develop a corresponding framework to achieve those targets. The research questions of this paper are (1) Do long-term scenarios (in particular those labelled as ambitious) of energy demand in buildings reflect the COP21 target? (2) If not: What are reasons for the gap in terms of scenario assumptions, in particular, regarding the policy framework in the corresponding scenarios? The method builds on following steps: (1) analysis of GHG-emission reduction in scenarios from the policy-driven, bottom-up model Invert/EE-Lab; (2) compare scenarios among each other and analyse if they are in line with Paris targets; (3) discuss possible explanations for any gaps and the implications on future modelling work and policy making. Results show that scenarios labelled as being Bambitious^for several EU MSs achieve GHGemission reductions of 56-96% until 2050. However, just 27% of these ambitious scenarios achieve reductions above 85%. The reason is that policies for most of the modelled scenarios were developed together with policy makers and stakeholders, who-for different reasons-were not willing to go beyond a certain stringency in the modelled instruments. In particular, this was the case for regulatory instruments, which show to be essential for achieving ambitious climate targets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.